Dow Up 0.17% Nasdaq Up 0.29%

Celgene Corporation (CELG)

-NasdaqGS
95.65 2.25(2.41%) Aug 26, 4:00PM EDT
Prev Close:93.40
Open:94.90
Bid:95.30 x 200
Ask:96.98 x 200
1y Target Est:100.03
Beta:1.1
Next Earnings Date:23-Oct-14CELG Earnings announcement
Day's Range:93.67 - 95.84
52wk Range:66.85 - 95.84
Volume:5,680,656
Avg Vol (3m):4,627,080
Market Cap:76.48B
P/E (ttm):30.44
EPS (ttm):3.14
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
CELGUp 2.41%76.48B
JNJ291.73B

Key Statistics

Forward P/E (1 yr):19.56
P/S (ttm):10.62
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :3.67
Quarterly EPS Est (Sep-14) :0.95
Mean Recommendation*:1.8
PEG Ratio (5 yr expected):0.99

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Celgene Corporation, a biopharmaceutical company, discovers, develops, and commercializes therapies to treat cancer and immune-inflammatory related diseases in the United States and internationally. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback